Skip to the page

Data / Form D filings / Balanced Pharma Inc

Balanced Pharma Inc: Form D filings

Balanced Pharma Inc, a pharmaceuticals company in Cornelius, NC, filed 6 Form D notices with the SEC between 2021 and 2025. The latest, on September 23, 2025, reports $3.2 million sold of a $3.2 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
18204 MAINSAIL POINTE, Cornelius, NC, 28031
Phone
(704) 650-0249
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1838860

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 23, 2025Amendment$3,200,000$3,200,0001Nov 27, 2024sec.gov
Jan 15, 2025New notice$2,000,000$175,000$1,825,0002Dec 31, 2024sec.gov
Dec 12, 2024New notice$498,000$498,00019Dec 12, 2024sec.gov
Dec 12, 2024New notice$2,000,000$2,000,0001Nov 27, 2024sec.gov
Feb 18, 2022Amendment$2,011,300$2,011,30044Dec 16, 2020sec.gov
Jan 7, 2021New notice$656,250$481,125$175,1258Dec 16, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
MARK SCOTT SEBREEDirector
JOHN SCOTT KEADLEExecutive Officer, Director
JOHN SCOTT SELIGDirector
ATIF SCOTT ZIADirector
RICHARD SCOTT NONELLEDirector

Other pharmaceuticals companies in North Carolina that filed recently

Every Form D from the week of Sep 22, 2025 · All recent filings in North Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Balanced Pharma Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.